Stage IIIC Prostate Cancer AJCC v8 Completed Phase 2 Trials for Prednisone (DB00635)

IndicationStatusPhase
DBCOND0109672 (Stage IIIC Prostate Cancer AJCC v8)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03279250Apalutamide and Gonadotropin-Releasing Hormone Analog With or Without Abiraterone Acetate in Treating Participants With Prostate CancerTreatment